Skip to main content
Premium Trial:

Request an Annual Quote

Akonni Raises $935K as It Targets $20M in Private Offering

NEW YORK (GenomeWeb News) – Akonni Biosystems has raised about $935,000 of a targeted $20 million offering, the molecular diagnostics firm disclosed in a document filed with the US Securities and Exchange Commission.

The raise is in the form of equity, it said. The company said three investors participated in the round but did not identify them. It also did not provide an intended use of the proceeds and did not respond to a request for comment.

Based in Frederick, Md., Akonni develops, manufactures, and markets integrated molecular diagnostic systems. For the clinical markets, its lead platform is the Akonni TruDiagnosis system, which uses gel-drop microarrays. It also offers Akonni TruTip kits for extracting nucleic acids for the life science research market.

A year ago, the company said in an SEC filing that it was seeking to raise $8 million.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.